Clolar
Showing 1 - 25 of 87
Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)
Recruiting
- Acute Myeloid Leukemia
- Pediatric Cancer
- Uproleselan
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 24, 2022
AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)
Recruiting
- AML
- +8 more
- Clofarabine
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 13, 2022
Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia
Completed
- Acute Lymphoblastic Leukemia
- Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
- Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Minimal Residual Disease, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Charlotte, Seattle (Clofarabine,
Terminated
- Minimal Residual Disease
- +2 more
- Clofarabine
- +3 more
-
Charlotte, North Carolina
- +1 more
Oct 4, 2021
MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)
Completed
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia (AML)
-
Chicago, Illinois
- +5 more
Mar 15, 2022
Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,
Completed
- Disorder Related to Bone Marrow Transplantation
- +2 more
- Fludarabine
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 18, 2021
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
-
Valhalla, New York
- +1 more
Oct 29, 2021
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +6 more
- clofarabine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)
Active, not recruiting
- Langerhans Cell Histiocytosis
-
Phoenix, Arizona
- +14 more
Mar 28, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine 40mg/m^2
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 3, 2020
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Jan 6, 2021
Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)
Terminated
- Acute Lymphoblastic Leukemia
- Alemtuzumab
- Clofarabine
-
La Jolla, California
- +2 more
Jul 29, 2020
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)
Completed
- Stem Cell Transplantation
- +2 more
- Thiotepa
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 25, 2020
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)
Completed
- Myelodysplastic Syndrome
- Leukemia
- Cord Blood Infusion
- +11 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 27, 2020
Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco
Terminated
- Myeloid Malignancy
- +5 more
- Alemtuzumab
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 25, 2020
Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)
Completed
- Leukemia
- Clofarabine
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 17, 2020
Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia Trial in Columbus, Madison, Milwaukee (Clofarabine, Cyclophosphamide,
Terminated
- Leukemia, Acute Lymphoblastic
- Acute Myeloid Leukemia
- Clofarabine
- +2 more
-
Columbus, Ohio
- +3 more
Feb 18, 2020